___

• 1. Mazza, G., Cacace, J., & Kay, C. (2004). Methods of analysis for anthocyanins in plants and biological fluids. J. AOAC Int, 87(1), 129-145.
• 2. M. Yang, S. K. (2011). Food Matrix Affecting Anthocyanin Bioavailability: Review. Current Medicinal Chemistry, 18, 291-300.
• 3. Pascural-Teresa, S. M.-A.-V. (2010). Flavanols and anthocyanins in cardiovascular health: A review of current evidence. Int. J. Mol. Sci, 11, 1679–1703.
• 4. Tsuda, T. (2012). Dietary anthocyanin-rich plants: Biochemical basis and recent progress in health benefits studies. Mol. Nutr. Food Res., 56, 159–170.
• 5. Castañeda-Ovando A, P.-H. M.-H.-V. (2009). Chemical studies of anthocyanins: a review. Food Chem, 113, 859–871.
• 6. Smeriglio A., B. D. (2016). Chemistry, Pharmacology and Health Benefits of Anthociyanins. Phytother. Res. doi:10.1002/ptr.5642
• 7. Lucioli, S. (2012). Anthocyanins: mechanism of action and therapeutic efficacy. In Medicinal Plants as Antioxidant Agents: Understanding Their Mechanism of Action and Therapeutic Efficacy,. (C. A, Dü.) 27-57. doi:97881-308-0509-2.
• 8. Pojer E, M. F. (2013). The case for anthocyanin consumption to promote human health: a review. Comp Rev Food Sci Food Safety, 12, 483–508.
• 9. John Overall, M. A. (2017). Anthocyanins in metabolic health and disease. Nutrigenomics and Proteomics in Health and Disease: Towards a Systems-Level Understanding of Gene–Diet Interactions, Second Edition, 92-124.
• 10. Wu X, B. G. (2006). Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem, 54(11), 4069–4075.
• 11. Kay, C. K. (2009). The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products. Mol Nutr Food Res., 53(1), 92-101.
• 12. Rosalind Miller, S. P. (2013). Potential Health Benefits of Blackcurrants. Bioactives in Fruit: Health Benefits and Functional Foods, First Edition. Edited by Margot Skinner and Denise Hunter., 215-250.
• 13. Øyvind M Andersen, M. J. (2010). Anthocyanins. Encyclopedia of Life Sciences (ELS), 1-12.
• 14. Milbury, P. E.-C. (2007). Bilberry (Vaccinium myrtillus) anthocyanins modulate heme oxygenase-1 and glutathione S-transferase-pi expression in ARPE-19 cells. Invest. Ophthalmol. Vis. Sci., 48, 2343–2349.
• 15. Prior, R. L. (2008). Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J. Agric. Food Chem., 56, 647–653.
• 16. Erlund I, K. R. (2008). Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr, 87, 323–331.
• 17. Shukitt-Hale, B. K.-T. (2009). Plum juice, but not dried plum powder, is effective in mitigating cognitive deficits in aged rats. Nutrition, 25, 567–573.
• 18. Bei, R., Masuelli, L., Turriziani, M., Li Volti, G., Malaguarnera, M., & Galvano, F. (2009). Impaired expression and function of signaling pathway enzymes by anthocyanins: role on cancer prevention and progression. Curr. Enzyme Inhib., 5, 184-197.
• 19. Russo, A., La Fauci, L., Acquaviva, R., Campisi, A., Raciti, G., Scifo, C., . . . Galvano, F. (2005). Ochratoxin A-induced DNA damage in human fibroblast:protective effect of cyanidin 3-O-beta-d-glucoside. J. Nutr. Biochem., 16(1), 31-37.
• 20. Yan X., M. B. (2002). Antioxidant activities and antitumor screening of extracts from cranberry fruit(Vaccinium macrocarpon). J. Agric. Food Chem., 50(21), 5844-5849.
• 21. Chen G., L. J. (2010). Anthocyanins: are they beneficial in treating ethanol neurotoxicity? Neurotox. Res., 17(1), 91-101.
• 22. Shih P.H., C. Y. (2010). Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry(Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer's disease. J. Nutr. Biochem., 21(7), 598-605.
• 23. He J, G. M. (2010). Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol, 1, 163-187.
• 24. Tsuda T., H. F. (2003). Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr., 133(7), 2125-2130.
• 25. Tsuda, T. U. (2004). Anthocyanin enhances adipocytokine secretion and adipocyte Anthocyanin enhances adipocytokine secretion and adipocyte specific gene expression in isolated rat adipocytes. Biochem Biophys Res Commun, 316, 149-157.
• 26. Arita, Y. K. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 257, 79-83.
• 27. Sasaki, R. N. (2007). Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol, 74, 1619–1627.
• 28. Prior, R. L. (2010). Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J. Agric. Food Chem., 58, 3970–3976.
• 29. Takikawa, M. I. (2010). Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated. J. Nutr., 140, 527-533.
• 30. Yamauchi, T. K. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7, 941–946.
• 31. Berg, A. C. (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab., 13, 84-89.
• 32. Lindsay, R. F. (2002). Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 360, 57–58.
• 33. Svegliati-Baroni, G. C. (2006). A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am. J. Pathol., 169, 846–860.
• 34. Yang, Q. G. (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436, 356–362.
• 35. Torronen, R. S. (2010). Berries modify the postprandial plasma glucose response to sucrose in healthy subjects. Br. J. Nutr., 103, 1094–1097.
• 36. Torronen, R. S. (2012). Postprandial glucose, insulin and glucagon-like peptide 1 responses to sucrose ingested with berries in healthy subjects. Br. J. Nutr., 107, 1445–1451.
• 37. Wood, P. (2007). Cereal b-glucans in diet and health. J Cereal Sci, 46, 230-238.
• 38. Hardie, D. G. (2008). Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett, 582, 81-89.
• 39. Wallace TC, S. M. (2016). Systematic review of anthocyanins and markers of cardiovascular disease. Nutrients, 8(1), 32-45.
• 40. Stocker, R. a. (2004). Role of oxidative modifications in atherosclerosis. Physiol Rev., 84, 1381–1478.
• 41. Tsuda, T. M. (1994). Antioxidative activity of the anthocyanin pigments cyanidin 3-O-beta-D-glucoside and cyanidin. J Agric Food Chem, 2407–2410.
• 42. Rice-Evans, C. M. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med, 20, 933–956.
• 43. Hassellund SS, F. A. (2013). Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebocontrolled crossover study. J Hum Hypertens, 27(2), 100-106.
• 44. Serraino I, D. L. (2003). Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Life Sci, 73(9), 1097–1114.
• 45. Kawashima, S. a. (2004). Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol, 24, 998-1005.
• 46. Rissanen, T. H. (2003). Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. J. Nutr., 133, 199–204.
• 47. Mink PJ, S. C. (2007). Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr, 85(3), 895-909
• 48. Ellingsen I, H. E. (2008). Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men. Br. J. Nutr., 99(3), 674–681.
• 49. Cassidy, A. O. (2010). Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr, 93, 338–347.
• 50. McCullough, M. P. (2012). Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr, 95(2), 454–464.
• 51. Qin, Y. X. (2009). Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr, 90, 485-492.
• 52. Zhu, Y. X. (2011). Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem., 57, 1524–1533.
• 53. Halliwell, B. (2008). Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys, 476(2), 107-112.
• 54. Ghosh D, K. T. (2007a). Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr, 16, 200-208.
• 55. Nakaishi, H. M. (2000). Effects of blackcurrant anthocyanosides intake on dark adaptation and VDT work-induced transient refractive alternation in healthy humans. Altern. Med. Rev., 5, 553-562.
• 56. Rendeiro C, G. J. (2012). Flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects. Proc Nutr Soc., 71(2), 246-262.
• 57. Krikorian, R. S. (2010). Blueberry supplementation improves memory in older adults. J. Agric. Food Chem, 58, 3996–4000.
• 58. Kang SY, S. N. (2003). Tat cherry anthocyanins inhibit tumor development in ApcMin mice and reduce proliferation of human colon cancer cells. . Cancer Lett, 194(1), 13-19.
• 59. Seeram NP., Momin RA., Nair MG. (2001). Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine, 8, 362-369.
• 60. Wang JA. (2002). Effects of anthocyanins and other phenolic compounds on the production of tumor necrosis factor alpha in LPS/IFN-gamma-activated RAW 264.7 macrophages. J Agric Food Chem, 50(15), 4183-4189.